Colgate Palmolive Co (CL) · Oct 30, 2026 · Earnings

Colgate earnings beat as guidance rises, but North America stays weak

Beat — Diluted EPS $0.94 vs ~$0.93 consensus; base-business EPS $0.97

Colgate-Palmolive’s Q3 earnings narrowly beat consensus, while stronger margins and EPS guidance lifted the full-year outlook despite weak North American volumes.

Colgate-Palmolive is in the middle of its 2030 growth strategy, leaning on premium innovation, brand investment, emerging-market expansion and Hill’s Pet Nutrition while trying to recover volumes in North America. Its prior-quarter story was already improving: worldwide organic volume had increased sequentially for a third straight quarter, but North America remained the weak spot.

The quarter cleared a modest market bar. Net sales of $5.369 billion exceeded the published consensus of roughly $5.34 billion, while diluted EPS of $0.94 topped consensus near $0.93. That is a narrow earnings beat, not a blowout, but the underlying result was better than the headline GAAP number: base-business EPS reached $0.97, up 7% year over year. The published consensus figures are externally sourced; the company’s reported results are from the filing. 〔0〕

Q3 2026Q3 2025Consensus
Net sales (Financial Highlights)$5,369 (+4.6%)$5,131~$5,340
Organic sales growth (Financial Highlights)3.6%——
Diluted EPS, GAAP (Financial Highlights)$0.94 (+3%)$0.91~$0.93
Base-business diluted EPS (Financial Highlights)$0.97 (+7%)$0.91—
Operating margin, base business (Operating Profit by Division)20.8% (+20 bps)20.6%—

Management raised the more important full-year framework. Organic sales growth is now expected to track the first nine months, implying roughly 3%, versus the prior 1%-4% range; GAAP and base-business gross margins are now expected to rise rather than remain roughly flat; and base-business EPS growth is now expected at 5%-7%, up from “mid-single-digit” growth. 〔1〕 〔2〕

The quality of growth improved, but the geography remains uneven. Total-company organic sales rose 3.6%, with volume contributing 1.7% and pricing 2.0%, while Latin America grew organic sales 12.5% and Hill’s Pet Nutrition 5.6%. North America, however, saw organic sales fall 1.6%, including a 3.7% volume decline, and its operating profit dropped 11% with a 210-basis-point margin contraction. That keeps the central execution problem intact even as the global portfolio performs well. 〔3〕

Margins and cash generation support the upgrade. Base-business operating margin expanded 20 basis points despite another double-digit advertising increase, and nine-month free cash flow before dividends rose to $2.513 billion from $2.358 billion. The improvement is meaningful because Colgate is funding brand investment and restructuring while still reducing debt less cash to $6.104 billion from $6.947 billion a year earlier. The caveat is that reported nine-month operating profit remains down 5% because of the Strategic Growth and Productivity Program, so the cleaner base-business trend is doing most of the work in the outlook.

Bottom line: This is better than a routine in-line quarter: Colgate beat a modest consensus bar and raised its full-year margin and EPS framework. The upgrade strengthens the global growth-and-productivity story, but North America’s volume weakness remains the unresolved drag on the business.

What to watch next

Q3 earnings call, October 30

Original filing on SEC EDGAR

Colgate earnings beat as guidance rises, but North America stays weak | CL Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.